Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis

The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer

(2013) Teresa Hemmerle et al.   INTERNATIONAL JOURNAL OF CANCER

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

(2013) Cem Gabay et al.   LANCET

Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse

(2013) Fabia Doll et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

(2011) Yusuf Yazici et al.   ANNALS OF THE RHEUMATIC DISEASES

The origin of tendon friction rubs in patients with systemic sclerosis: A sonographic explanation

(2011) Giovanna Cuomo et al.   ARTHRITIS AND RHEUMATISM

What determines Th2 differentiation, in vitro and in vivo ?

(2010) William E Paul   IMMUNOLOGY AND CELL BIOLOGY

Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies

(2009) Marta Pedretti et al.   ATHEROSCLEROSIS

Treatment of rheumatoid arthritis: state of the art 2009

(2009) Ronald F. van Vollenhoven   Nature Reviews Rheumatology

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

(2009) Kathrin Schwager et al.   ARTHRITIS RESEARCH & THERAPY

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo

(2008) Alessandra Villa et al.   INTERNATIONAL JOURNAL OF CANCER